226 related articles for article (PubMed ID: 27275197)
1. Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.
Khateeb EE; Morgan D
Open Access Maced J Med Sci; 2015 Mar; 3(1):57-62. PubMed ID: 27275197
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
3. [Expression of PRAME gene in adult acute leukemia and its significance in prognosis].
Zhou PY; Li WJ; Wei CX; Zhou Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1177-81. PubMed ID: 18088461
[TBL] [Abstract][Full Text] [Related]
4. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Mo XD; Qin YZ; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2016 Aug; 95(8):1233-40. PubMed ID: 27302479
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
Qin Y; Zhu H; Jiang B; Li J; Lu X; Li L; Ruan G; Liu Y; Chen S; Huang X
Leuk Res; 2009 Mar; 33(3):384-90. PubMed ID: 18950857
[TBL] [Abstract][Full Text] [Related]
7. WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML).
Steger B; Floro L; Amberger DC; Kroell T; Tischer J; Kolb HJ; Schmetzer HM
J Immunother; 2020; 43(6):204-215. PubMed ID: 32502139
[TBL] [Abstract][Full Text] [Related]
8. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
9. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.
Huang QS; Wang JZ; Qin YZ; Zeng QZ; Jiang Q; Jiang H; Lu J; Liu HX; Liu Y; Wang JB; Su L; Zhang HY; Li ZL; Gao SJ; Huang B; Liu YY; Liu YR; Xu LP; Huang XJ; Zhang XH
Blood Adv; 2019 Nov; 3(21):3406-3418. PubMed ID: 31714962
[TBL] [Abstract][Full Text] [Related]
11. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
12. PRAME gene expression in childhood acute lymphoblastic leukemia.
Steinbach D; Viehmann S; Zintl F; Gruhn B
Cancer Genet Cytogenet; 2002 Oct; 138(1):89-91. PubMed ID: 12419593
[TBL] [Abstract][Full Text] [Related]
13. [Expression of PRAME gene in acute leukemia and its clinical significance].
Zhu YL; Liu J; Zhu P; DU JW; Zhang Y; Gu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1144-9. PubMed ID: 18088454
[TBL] [Abstract][Full Text] [Related]
14. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
[TBL] [Abstract][Full Text] [Related]
15. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
[TBL] [Abstract][Full Text] [Related]
16. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.
Tajeddine N; Millard I; Gailly P; Gala JL
Clin Chem Lab Med; 2006; 44(5):548-55. PubMed ID: 16681423
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the
Zhang F; Lu AD; Zuo YX; Ding MM; Jia YP; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):543-549. PubMed ID: 35644195
[TBL] [Abstract][Full Text] [Related]
18. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
Gaiger A; Linnerth B; Mann G; Schmid D; Heinze G; Tisljar K; Haas OA; Gadner H; Lion T
Eur J Haematol; 1999 Aug; 63(2):86-93. PubMed ID: 10480287
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia.
Nowakowska-Kopera A; Sacha T; Florek I; Zawada M; Czekalska S; Skotnicki AB
Leuk Lymphoma; 2009 Aug; 50(8):1326-32. PubMed ID: 19811333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
